Danaher Corporation (DHR): are the analysts right?

Danaher Corporation · Health Care · ref. ETF XLV · 61 calls · price $194.19
What the company does: Danaher Corporation fabrique et commercialise des produits et services professionnels, médicaux, de recherche et industriels via ses segments Biotechnologie, Sciences de la vie et Diagnostics.
📈 1-year price
$194.19-3.2% over range
Jul 8, 25low $161.91 · high $242.05Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
77% recommend buying · 13 analysts

🎯 Analyst price target on DHR

High target · 1 analyst$275+41.6%
Median target · 13 analysts$230+18.4%
Low target · 1 analyst$95-51.1%
Current price$194.19

🗳️ The analyst consensus

Analyst breakdown · 13 (6 months)
Strong Buy0%
Buy77%
Hold23%
Sell0%
Strong Sell0%

💰 Danaher Corporation dividend

0.74%annual yield
📈 Steady dividend8 yrs of consecutive dividend increases
That's ~$1.44 per share per year.

✅ Historical analyst reliability on DHR

Most reliable analysts on DHR (% profitable · 365j · ≥2 calls)
Baird 67% -1.5% 3
RBC Capital 50% -4.7% 2
Barclays 42% +2.7% 12

📊 What $1,000 invested in Danaher Corporation would be worth

In short — $1,000 invested in Danaher Corporation 10 years ago would be worth $3,175 today, i.e. +12%/yr on average. Best year: 2020 (+52%), worst: 2024 (-18%). Price performance, excluding dividends.

If I'd invested $1,000 in Danaher Corporation

InvestmentWorth todayGain
1 years ago$917-8%
3 years ago$868-13%
5 years ago$978-2%
10 years ago$3,175+217%
since inception (1978)$2,133,035+213203%

Return by year (Danaher Corporation)

YearReturn$1,000 invested at year start
2026 (YTD)-10%$904 (-10%)
2025+1%$917 (-8%)
2024-18%$752 (-25%)
2023+15%$868 (-13%)
2022-10%$783 (-22%)
2021+25%$978 (-2%)
2020+52%$1,486 (+49%)
2019+14%$1,692 (+69%)
2018+30%$2,197 (+120%)
2017+14%$2,512 (+151%)
2016+26%$3,175 (+217%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on DHR

▲ Outperform · 🎯$230
Price at call : $194.19 — upside +18%
Today : $194.19 — upside +18%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jul 6, 27
Piper Sandler
Jun 11, 26
■ Neutral neutral · not a buy · 🎯$200
Price at call : $180.79 — gap to target +11%
Today : $194.19 — gap to target +3%
🎯 on DHR : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jun 11, 27
HSBC
Jun 3, 26
▲ Buy · 🎯$230
Price at call : $186.64 — upside +23%
Today : $194.19 — upside +18%
🎯 on DHR : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Jun 3, 27
Citigroup
May 27, 26
■ Neutral neutral · not a buy · 🎯$95
Price at call : $180.63 — gap to target -47%
Today : $194.19 — gap to target -51%
🎯 on DHR : 100% (1 call matured) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 27, 27
▲ Overweight · 🎯$255
Price at call : $177.25 — upside +44%
Today : $194.19 — upside +31%
🎯 on DHR : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Apr 23, 27
UBS
Apr 22, 26
▲ Buy · 🎯$250
Price at call : $178.57 — upside +40%
Today : $194.19 — upside +29%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Apr 22, 27
Wells Fargo
Apr 22, 26
■ Equal-Weight neutral · not a buy · 🎯$212
Price at call : $178.57 — gap to target +19%
Today : $194.19 — gap to target +9%
🎯 on DHR : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Apr 22, 27
Guggenheim
Apr 22, 26
▲ Buy · 🎯$235
Price at call : $178.57 — upside +32%
Today : $194.19 — upside +21%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Apr 22, 27
Baird
Apr 22, 26
▲ Outperform · 🎯$245
Price at call : $184.04 — upside +33%
Today : $194.19 — upside +26%
🎯 on DHR : 67% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Apr 22, 27
Baird
Apr 17, 26
▲ Outperform · 🎯$249
Price at call : $194.75 — upside +28%
Today : $194.19 — upside +28%
🎯 on DHR : 67% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Apr 17, 27
Barclays
Apr 14, 26
▲ Overweight · 🎯$230
Price at call : $198.14 — upside +16%
Today : $194.19 — upside +18%
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Apr 14, 27
Goldman Sachs
Apr 13, 26
▲ Buy · 🎯$230
Price at call : $198.61 — upside +16%
Today : $194.19 — upside +18%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Apr 13, 27
▲ Outperform · 🎯$225
Price at call : $191.01 — upside +18%
Today : $194.19 — upside +16%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Apr 6, 27
JP Morgan
Jan 29, 26
▲ Overweight · 🎯$275
Price at call : $218.89 — upside +26%
Today : $194.19 — upside +42%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Jan 29, 27
Jefferies
Jan 29, 26
▲ Buy · 🎯$265
Price at call : $218.89 — upside +21%
Today : $194.19 — upside +36%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Jan 29, 27
TD Cowen
Jan 7, 26
▲ Buy · 🎯$270
Price at call : $235 — upside +15%
Today : $194.19 — upside +39%
🎯 on DHR : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Jan 7, 27
Guggenheim
Jan 5, 26
▲ Buy · 🎯$275
Price at call : $236.59 — upside +16%
Today : $194.19 — upside +42%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Jan 5, 27
Wells Fargo
Dec 15, 25
■ Equal-Weight neutral · not a buy · 🎯$240
Price at call : $224.7 — gap to target +7%
Today : $194.19 — gap to target +24%
🎯 on DHR : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Dec 15, 26
▲ Buy · 🎯$265
Price at call : $223.23 — upside +19%
Today : $194.19 — upside +36%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Dec 9, 26
▲ Overweight · 🎯$270
Price at call : $228.46 — upside +18%
Today : $194.19 — upside +39%
🎯 on DHR : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 2, 26
Wells Fargo
Oct 23, 25
■ Equal-Weight neutral · not a buy · 🎯$230
Price at call : $222.73 — gap to target +3%
Today : $194.19 — gap to target +18%
🎯 on DHR : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Oct 23, 26
TD Cowen
Oct 22, 25
▲ Buy · 🎯$260
Price at call : $222.73 — upside +17%
Today : $194.19 — upside +34%
🎯 on DHR : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Oct 22, 26
Barclays
Oct 22, 25
▲ Overweight · 🎯$250
Price at call : $218.1 — upside +15%
Today : $194.19 — upside +29%
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 22, 26
■ Neutral neutral · not a buy · 🎯$220
Price at call : $204.96 — gap to target +7%
Today : $194.19 — gap to target +13%
🎯 on DHR : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Oct 8, 26
▲ Outperform · 🎯$245
Price at call : $204.96 — upside +20%
Today : $194.19 — upside +26%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Oct 7, 26
▲ Buy · 🎯$220
Price at call : $189.72 — upside +16%
Today : $194.19 — upside +13%
🎯 on DHR : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Sep 22, 26
UBS
Jul 23, 25
▲ Buy · 🎯$225
Price at call : $202.81 — upside +11%
Today : $194.19 — upside +16%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jul 23, 26
Wells Fargo
Jul 23, 25
■ Equal-Weight neutral · not a buy · 🎯$205
Price at call : $202.81 — gap to target +1%
Today : $194.19 — gap to target +6%
🎯 on DHR : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Jul 23, 26
Guggenheim
Jul 23, 25
▲ Buy · 🎯$250
Price at call : $197.89 — upside +26%
Today : $194.19 — upside +29%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Jul 23, 26
Baird
Jul 23, 25
▲ Outperform · 🎯$229
Price at call : $197.89 — upside +16%
Today : $194.19 — upside +18%
🎯 on DHR : 67% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jul 23, 26
Baird
Jul 18, 25
▲ Outperform · 🎯$226
Price at call : $190.05 — upside +19%
Today : $194.19 — upside +16%
🎯 on DHR : 67% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jul 18, 26
Scotiabank
Jul 11, 25
▲ Sector Outperform · 🎯$275
Price at call : $204.85 — upside +34%
Today : $194.19 — upside +42%
🎯 on DHR : no call matured yet · 📊 on Health : 16.7% · -12.6% (6 calls)
in progress (365j)
matures : Jul 11, 26
▲ Outperform · 🎯$226
Price at call : $200.68 — upside +13%
Today : $194.19 — upside +16%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jul 8, 26
Barclays
Jun 24, 25
▲ Overweight · 🎯$225
Price at call : $201 — upside +12%
Today : $194.19 — upside +16%
Expected +12% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-3.9%
stock -4% · XLV +16%
RBC Capital
Apr 23, 25
▲ Outperform · 🎯$250
Price at call : $196.5 — upside +27%
Today : $194.19 — upside +29%
Expected +27% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 50% (2 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
-9.8%
stock -10% · XLV +5%
Goldman Sachs
Apr 23, 25
▲ Buy · 🎯$240
Price at call : $196.5 — upside +22%
Today : $194.19 — upside +24%
Expected +22% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 50.8% · +2.0% (240 calls)
-9.8%
stock -10% · XLV +5%
Guggenheim
Apr 23, 25
▲ Buy · 🎯$250
Price at call : $196.5 — upside +27%
Today : $194.19 — upside +29%
Expected +27% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 52.8% · +3.9% (89 calls)
-9.8%
stock -10% · XLV +5%
UBS
Apr 23, 25
▲ Buy · 🎯$240
Price at call : $196.5 — upside +22%
Today : $194.19 — upside +24%
Expected +22% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
-9.8%
stock -10% · XLV +5%
Baird
Apr 23, 25
▲ Outperform · 🎯$225
Price at call : $196.31 — upside +15%
Today : $194.19 — upside +16%
Expected +15% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 67% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
-9.0%
stock -9% · XLV +8%
Barclays
Apr 22, 25
▲ Overweight · 🎯$215
Price at call : $196.31 — upside +10%
Today : $194.19 — upside +11%
Expected +10% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-9.0%
stock -9% · XLV +8%
JP Morgan
Apr 22, 25
▲ Overweight · 🎯$260
Price at call : $196.31 — upside +32%
Today : $194.19 — upside +34%
Expected +32% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 53.6% · +5.2% (349 calls)
-9.0%
stock -9% · XLV +8%
Jefferies
Apr 22, 25
▲ Buy · 🎯$230
Price at call : $196.31 — upside +17%
Today : $194.19 — upside +18%
Expected +17% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 50.5% · +4.5% (376 calls)
-9.0%
stock -9% · XLV +8%
Baird
Apr 16, 25
▲ Outperform · 🎯$231
Price at call : $186.83 — upside +24%
Today : $194.19 — upside +19%
Expected +24% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 67% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+4.2%
stock +4% · XLV +10%
Barclays
Apr 10, 25
▲ Overweight · 🎯$205
Price at call : $180.76 — upside +13%
Today : $194.19 — upside +6%
Expected +13% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+4.9%
stock +5% · XLV +9%
Stifel
Mar 14, 25
▲ Buy · 🎯$260
Price at call : $212.6 — upside +22%
Today : $194.19 — upside +34%
Expected +22% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 51.2% · +8.2% (297 calls)
-10.0%
stock -10% · XLV +3%
■ Market Perform neutral · not a buy
🎯 on DHR : no call matured yet · 📊 on Health : 46.8% · +2.0% (395 calls)
in progress (365j)
matures : Feb 3, 26
Citigroup
Jan 30, 25
▲ Buy · 🎯$265
Price at call : $222.74 — upside +19%
Today : $194.19 — upside +36%
Expected +19% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 100% (1 call matured) · 📊 on Health : 53.4% · +2.8% (496 calls)
+0.3%
stock +0% · XLV +6%
RBC Capital
Jan 30, 25
▲ Outperform · 🎯$277
Price at call : $222.74 — upside +24%
Today : $194.19 — upside +43%
Expected +24% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 50% (2 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+0.3%
stock +0% · XLV +6%
Baird
Jan 30, 25
▲ Outperform · 🎯$258
Price at call : $222.74 — upside +16%
Today : $194.19 — upside +33%
Expected +16% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 67% (3 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+0.3%
stock +0% · XLV +6%
Wells Fargo
Jan 30, 25
■ Equal-Weight neutral · not a buy · 🎯$240
Price at call : $223.08 — gap to target +8%
Today : $194.19 — gap to target +24%
🎯 on DHR : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Jan 30, 26
▲ Outperform · 🎯$280
Price at call : $270.09 — upside +4%
Today : $194.19 — upside +44%
Expected +4% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 57.1% · +6.2% (35 calls)
-23.9%
stock -24% · XLV -8%
Barclays
Oct 26, 23
▲ Overweight · 🎯$215
Price at call : $193.68 — upside +11%
Today : $194.19 — upside +11%
Expected +11% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+26.7%
stock +27% · XLV +19%
Barclays
Jul 26, 23
▲ Overweight · 🎯$290
Price at call : $234.81 — upside +24%
Today : $194.19 — upside +49%
Expected +24% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+15.0%
stock +15% · XLV +10%
Barclays
Apr 26, 23
▲ Overweight · 🎯$260
Price at call : $206.09 — upside +26%
Today : $194.19 — upside +34%
Expected +26% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+19.3%
stock +19% · XLV +6%
Barclays
Apr 4, 23
▲ Overweight · 🎯$270
Price at call : $220.73 — upside +22%
Today : $194.19 — upside +39%
Expected +22% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+10.7%
stock +11% · XLV +10%
Barclays
Jan 24, 23
▲ Overweight · 🎯$290
Price at call : $240.76 — upside +20%
Today : $194.19 — upside +49%
Expected +20% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-5.1%
stock -5% · XLV +4%
Barclays
Nov 29, 22
▲ Overweight · 🎯$277
Price at call : $229.63 — upside +21%
Today : $194.19 — upside +43%
Expected +21% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-3.1%
stock -3% · XLV -4%
Barclays
Oct 6, 22
▲ Overweight · 🎯$305
Price at call : $246.5 — upside +24%
Today : $194.19 — upside +57%
Expected +24% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-11.9%
stock -12% · XLV +4%
Barclays
Jul 22, 22
▲ Overweight · 🎯$310
Price at call : $242.77 — upside +28%
Today : $194.19 — upside +60%
Expected +28% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-5.8%
stock -6% · XLV +5%
Barclays
Jul 13, 22
▲ Overweight · 🎯$290
Price at call : $222.6 — upside +30%
Today : $194.19 — upside +49%
Expected +30% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-4.9%
stock -5% · XLV +2%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)